Taysha Gene TherapiesTSHA
那斯達克 · USD
4.72
+0.06
(+1.18%)
盤中 01/27 01:36 (UTC+8)
01/27 01:36 (UTC+8)
Taysha Gene TherapiesTSHA
4.72
+0.06
(+1.18%)
財務數據
損益表
- 0.02
- 0.05
- 0.04
- 0.03
- 0.01
- 0.02
- 0.02
- 0.02
- 0.02
- -
- -49.11
- 98.16
- -24.06
- -5.36
- -67.40
- 60.79
- 13.09
- 13.85
- -13.73
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | - | 1,986 | 2,302 | 2,022 | 1,788 | 1,112 | 3,411 | 3,604 | 4,746 | 2,395 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | 1,986 | 2,302 | 2,022 | 1,788 | 1,112 | 3,411 | 3,604 | 4,746 | 2,395 |
營業費用 | 34,024 | 28,739 | - | 21,954 | - | - | - | 19,850 | 20,996 | 25,779 |
研發費用 | 25,745 | 20,141 | 15,565 | 15,325 | 14,946 | 15,073 | 20,657 | 12,682 | 11,791 | 19,791 |
推銷及管理費用 | 8,279 | 8,598 | 8,158 | 6,629 | 7,902 | 7,338 | 7,084 | 6,719 | 8,589 | 5,988 |
非經常性項目費用 | - | - | - | - | 4,838 | - | - | 449 | 616 | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -34,024 | -26,753 | -21,421 | -19,932 | -25,898 | -21,299 | -24,330 | -16,246 | -16,250 | -23,384 |
其他收入及費用 | 1,306 | -112 | -89 | 1,169 | 398 | 398 | 298 | 64,700 | -99,366 | 226 |
利息費用 | 15 | 17 | 19 | 22 | 24 | 27 | 29 | 713 | 1,471 | 1,440 |
稅前純益 | -32,733 | -26,882 | -21,529 | -18,785 | -25,524 | -20,928 | -24,061 | 47,741 | -117,087 | -24,598 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -32,733 | -26,882 | -21,529 | -18,785 | -25,524 | -20,928 | -24,061 | 47,741 | -117,087 | -24,598 |
基本每股稅後盈餘(元) | -0.09 | -0.09 | -0.08 | -0.07 | -0.10 | -0.09 | -0.10 | - | -0.93 | -0.38 |
稀釋每股稅後盈餘(元) | -0.09 | -0.09 | -0.08 | -0.07 | -0.10 | -0.09 | -0.10 | 0.92 | -1.22 | -0.38 |
基本平均股數(千股) | 353309.00 | 297988.00 | 269306.00 | 268643.00 | 267824.00 | 232821.00 | 231249.00 | - | 125700.00 | 64244.00 |
稀釋平均股數(千股) | 353309.00 | 297988.00 | 269306.00 | 268643.00 | 267824.00 | 232821.00 | 231249.00 | - | 125700.00 | 64244.00 |
還原基本每股稅後盈餘(元) | -0.09 | -0.09 | -0.08 | -0.07 | -0.10 | -0.09 | -0.10 | - | -0.93 | -0.38 |
還原稀釋每股稅後盈餘(元) | -0.09 | -0.09 | -0.08 | -0.07 | -0.10 | -0.09 | -0.10 | 0.92 | -1.22 | -0.38 |
還原基本平均股數(千股) | 353,309 | 297,988 | 269,306 | 268,643 | 267,824 | 232,821 | 231,249 | - | 125,700 | 64,244 |
還原稀釋平均股數(千股) | 353,309 | 297,988 | 269,306 | 268,643 | 267,824 | 232,821 | 231,249 | - | 125,700 | 64,244 |
EBITDA(千元) | -32,432 | -26,588 | -21,227 | -18,459 | -25,206 | -20,579 | -23,707 | 48,820 | -115,285 | -22,815 |